我国抗菌药物临床管理仍需关注的几个问题  

Refocus on some issues of antimicrobial stewardship in China

作　　者：陈志东[1] CHEN Zhidong(Department of Pharmacy,Shanghai 6th People＇s Hospital,Shanghai Jiao Tong University,Shanghai 200233,China)

机构地区：[1]上海交通大学附属第六人民医院药剂科,上海200233

出　　处：《上海医药》2018年第21期16-21,共6页Shanghai Medical & Pharmaceutical Journal

摘　　要：随着抗菌药物临床管理相关规定(规范)的实施,我国抗菌药物使用强度已由2010年的77.6 DDDs降至2017年的45.7 DDDs。但2017年的监测结果显示,抗菌药物不合理使用的现象仍普遍存在,故还需持续关注有关文件的落实、药师处方审核的能力、抗菌药物临床管理数据的质量和抗菌药物约定日剂量的调整、新增情况等。Over decade has passed since focusing on antimicrobial stewardship （AMS）, the DDDs per 100 occupied bed days has fallen to 45.7 DDDs in 2017 from 77.6 DDDs in 2010 in China. But according to 2017 surveillance results of antimicrobial use, the irrational antimicrobial use by patients and healthcare providers has been widespread. Some issues should be refocused on, including document implementation of AMS, prescription checking of pharmacists, data quality of AMS, and alterations/news of antimicrobial defined daily dose by the WHO Collaborating Centre for Drug Statistics Methodology in Oslo.

关 键 词：抗菌药物临床管理 处方审核 约定日剂量 

分 类 号：R951[医药卫生—药学] R978